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Abstract
Background: Inadequate maternal nutrition during early fetal development can create permanent alterations in the
offspring, leading to poor health outcomes. While nutrients involved in one-carbon cycle metabolism are important to
fetal growth, associations with specific nutrients remain inconsistent. This study estimates associations between maternal
vitamins B12, B6 (pyridoxal phosphate [PLP] and 4-pyridoxic acid [PA]), and homocysteine (Hcy) concentrations, offspring
weight (birth weight and 3-year weight gain), and DNA methylation at four differentially methylated regions (DMRs)
known to be involved in fetal growth and development (H19, MEG3, SGCE/PEG10, and PLAGL1).
Methods: Study participants (n = 496) with biomarker and birth weight data were enrolled as part of the Newborn
Epigenetics STudy. Weight gain data were available for 273 offspring. Among 484 mother-infant pairs, DNA methylation
at regulatory sequences of genomically imprinted genes was measured in umbilical cord blood DNA using bisulfite
pyrosequencing. We used generalized linear models to estimate associations.
Results: Multivariate adjusted regression models revealed an inverse association between maternal Hcy concentration and
male birth weight (β=−210.40, standard error (SE) = 102.08, p= 0.04). The offspring of the mothers in the highest quartile
of B12 experienced lower weight gain between birth and 3 years compared to the offspring of the mothers in the lowest
(β=−2203.03, SE = 722.49, p= 0.003). Conversely, maternal PLP was associated with higher weight gain in males; higher
maternal PLP concentrations were also associated with offspring DNA methylation levels at the MEG3 DMR (p< 0.01).
Conclusions: While maternal concentrations of B12, B6, and Hcy do not associate with birth weight overall, they may
play an important role in 3-year weight gain. This is the first study to report an association between maternal PLP and
methylation at the MEG3 DMR which may be an important epigenetic tag for maternal B vitamin adequacy.
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Background
Size at birth is a strong predictor of infant growth and sur-
vival and has been linked to lifelong health outcomes [1].
Low birth weight (LBW, <2500 g) is associated with aug-
mented risk of adult chronic conditions including the fol-
lowing: obesity, cardiovascular disease, type 2 diabetes,
and some cancers [2, 3]. The period of intrauterine growth
may therefore be characterized by heightened vulnerability
from both endogenous and exogenous factors.
While maternal nutrition during fetal development has
been shown to have long-term health consequences for
the offspring [4], the impact of specific nutrients on fetal
and childhood outcomes remains unresolved. Nutrients
involved in one-carbon cycle (1-CC) metabolism are es-
sential for nucleic acid synthesis, DNA methylation, and
cellular growth [5]. These nutrients are particularly im-
portant in fetal tissue differentiation. Thus, deficiencies
in this pathway could be associated with fetal growth re-
striction, LBW, and early-life weight gain (WG). Under-
standing the association between these nutrients and
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offspring weight may be crucial in uncovering modifiable
ways to prevent LBW and downstream health effects.
The 1-CC metabolism pathway provides methyl groups
for DNA methylation reactions and is dependent on sev-
eral enzymes in the presence of dietary micronutrients.
Key micronutrients in this pathway include folate, choline,
and co-factors such as vitamins B6 and B12. While the lit-
erature supports an association between low maternal
blood folate concentrations and small size at birth [6], data
regarding associations between fetal growth and maternal
levels of vitamins B6, B12, and homocysteine (a marker of
impaired folate status) remain equivocal [7]. Further, data
linking maternal micronutrient concentrations to early-
life outcomes are limited [8].
Inadequate maternal 1-CC nutrients have been linked
to lower DNA methylation at the agouti locus [9] during
critical periods of early embryonic development, and in
this model epigenetic programs, the offspring to adult
obesity, diabetes, and cancer [10]. The plasticity of the
epigenome may offer a mechanistic link between mater-
nal nutrition and adult disease [11]. DNA methylation is
the most widely studied epigenetic modification and is
integral in regulating gene expression [12]. Despite the
importance of 1-CC nutrients in DNA methylation, few
studies have investigated whether maternal micronutrient
concentrations influence offspring DNA methylation pat-
terns [13–15], and most have primarily focused on folate.
The aim of this study was to examine the association
between maternal serum concentrations of vitamin B12
(B12), pyridoxal phosphate (PLP), 4-pyridoxic acid (PA),
homocysteine (Hcy), and offspring weight at birth
through age 3 years in an ethnically diverse population.
We further sought to explore the potential effects of ma-
ternal micronutrient concentrations on the methylation
patterns of genomically imprinted gene differentially
methylated regions (DMRs). While there are more than
80 recognized imprinted genes in humans [16], we selected
four DMRs (H19, MEG3, SGCE/PEG10, and PLAGL1)
known to be important in fetal growth and development
[17, 18] and previously associated with maternal B vitamin
concentrations in cross-sectional studies [13–15].
Results
The majority of women included in these analyses were
aged 20–29 years (56 %), were black (42 %), and had
low income (55 %). Notably, 26 % of the study participants
smoked prior to or during pregnancy, and a large propor-
tion of women supplemented with folic acid (FA) (89 %).
Blood draw occurred during the first trimester for most
participants (64 %). Table 1 provides the median (range)
for maternal micronutrient concentrations of B12, PLP,
PA, and Hcy by maternal and offspring characteristics.
Concentrations of PLP and PA were substantially (p <
0.05) lower among Black than White mothers.
Associations between maternal micronutrient concentrations
(e.g., B12, PLP, PA, and Hcy) and birth weight
The mean birth weight in our study sample was 3294 g
(standard deviation = 541 g). Table 2 presents adjusted
regression coefficient estimates (βs) and standard errors
(SE) for the multivariate association between maternal
micronutrient concentrations and infant birth weight, as
well as sex-specific estimates. All models adjusted for
race/ethnicity, gestational age at blood draw and deliv-
ery, marital status, parity, income, pre-pregnancy BMI,
and maternal smoking. While we observed a monotonic
increase in birth weight with increasing PLP and de-
crease in birth weight with increasing Hcy among all
participants, our estimates were imprecise.
We found that the inverse association between
Hcy and birth weight was most pronounced among
male infants. The coefficient estimate among male
infants in the highest quartile of maternal Hcy con-
centration was −210.40 (SE = 102.08, p = 0.04) while
the corresponding estimate among female infants
was 27.33 (SE = 98.14, p = 0.78). However, the cross-
product term was not statistically significant (p = 0.10). Al-
though we observed striking differences in the association
between maternal B6 (PLP and PA) concentration and
birth weight in infants born to women who reported FA
supplementation (Additional file 1: Table S1), the esti-
mates were imprecise due to the low proportion of non-
supplementing women. These associations did not vary by
race/ethnicity or maternal BMI, and exclusion of preterm
infants did not substantially alter our findings.
Associations between maternal micronutrient concentrations
(e.g., B12, PLP, PA, and Hcy) and age 3 weight gain
Among all 273 children with anthropometric data at age
3 years, the mean WG was 11,741 g (standard deviation =
2250 g). Table 3 shows the linear associations between
maternal micronutrient concentrations and age 3-year
WG adjusted for gestational age at blood draw, maternal
race/ethnicity, maternal pre-pregnancy BMI, household
income, breastfeeding, and age 3-year caloric intake. The
children of the mothers in the highest quartile of B12 con-
centrations experienced lower WG compared to the chil-
dren of the mothers in the lowest quartile (β = −2203.03,
SE = 722.49, p = 0.003). For maternal PLP concentrations,
there was some indication of differences in association by
offspring sex (βmales = 2943.29, SE = 1365.99, p = 0.04 and
βfemales = −1737.49, SE = 936.33, p = 0.08), but the differ-
ences were not significant at the 0.05 alpha level.
Associations between maternal micronutrient concentrations
and DNA methylation at DMRs regulating imprinted genes
We examined whether maternal micronutrient concen-
trations were associated with imprinted DMR methyla-
tion at the H19, MEG3, SGCE/PEG10, and PLAGL1
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Table 1 Study participant characteristics by maternal B vitamin concentrations: Newborn Epigenetic STudy (N = 496)
Variable B12 (ng/L) PLP (nM/L) PA (nM/L) Hcy (umoL/L)
N = 489 N = 496 N = 496 N = 480
N (%) Median (range)
Age at delivery (year)
20–29 278 (56%) 428.44 (56.13–2628.11) 6.66 (0.00–54.90) 2.85 (0.00–179.19) 0.69 (0.30–1.34)
18–< 20 22 (4%) 419.05 (216.96–834.27) 7.30 (1.25–32.19) 3.43 (0.00–24.92) 0.75 (0.44–0.98)
30–35 147 (30%) 495.38 (151.24–3664.91) 8.46 (0.00–173.86) 3.70 (0.00–218.44) 0.70 (0.33–1.54)
36+ 50 (10%) 411.46 (148.62–2779.17) 9.02 (0.41–76.90) 2.85 (0.00–122.61) 0.71 (0.35–1.07)
Race/ethnicity
Black 186 (42%) 431.76 (109.44–1249.75) 5.62 (0.00–34.58) 2.41 (0.00–130.60) 0.70 (0.30–1.54)
White 133 (30%) 493.67 (56.13–3664.91) 8.87 (0.00–173.86) 4.85 (0.00–218.44) 0.73 (0.44–1.19)
Hispanic 121 (28%) 432.25 (93.47–2779.17) 8.07 (1.60–30.24) 2.94 (0.00–30.01) 0.69 (0.33–1.22)
Preterm birth
Term 468 (94%) 444.02 (56.13–3664.91) 7.35 (0.00–173.86) 3.21 (0.00–218.44) 0.70 (0.30–1.54)
Preterm 29 (6%) 485.71 (162.05–891.89) 7.91 (0.00–34.58) 3.24 (0.00–30.01) 0.66 (0.33–1.08)
Marital status
Married 186 (38%) 485.98 (148.62–3664.91) 8.89 (0.00–173.86) 4.25 (0.00–218.44) 0.71 (0.30–1.22)
Never married 141 (29%) 443.03 (56.13–2628.11) 5.86 (0.95–34.58) 2.57 (0.00–130.60) 0.70 (0.35–1.34)
Living with partner 136 (28%) 406.87 (133.52–1570.18) 7.73 (0.00–31.59) 2.94 (0.00–35.09) 0.69 (0.44–1.54)
Other 28 (5%) 398.20 (128.05–2779.17) 7.55 (0.00–35.12) 2.55 (0.00–11.38) 0.71 (0.33–1.10)
Parity (at enrollment)
Multiparous 320 (65%) 443.89 (56.13–3664.91) 6.74 (0.00–173.86) 2.77 (0.00–218.44) 0.69 (0.33–1.54)
Nulliparous 176 (35%) 454.01 (109.44–1600.50) 9.02 (0.00–63.59) 4.34 (0.00–186.65) 0.71 (0.30–1.21)
Household income
<$25,000 215 (55%) 414.91 (128.05–2779.17) 6.66 (0.00–56.00) 2.71 (0.00–30.01) 0.68 (0.35–1.34)
$25,000–$49,999 54 (14%) 426.39 (162.05–855.61) 6.25 (0.00–173.86) 3.20 (0.00–218.44) 0.72 (0.30–1.54)
$50,000–$100,000 73 (18%) 500.13 (143.07–3664.91) 9.92 (0.00–76.90) 4.67 (0.00–179.19) 0.73 (0.43–1.19)
>$100,000 50 (13%) 507.86 (148.62–1600.50) 11.32 (1.34–63.59) 5.52 (0.79–186.65) 0.68 (0.44–1.10)
Education
College graduate 145 (29%) 508.50 (148.62–3664.91) 9.15 (0.00–173.86) 4.60 (0.00–218.44) 0.70 (0.30–1.21)
High school/GED 108 (22%) 381.84 (56.13–1038.75) 6.02 (0.00–54.90) 2.63 (0.00–179.19) 0.70 (0.40–1.14)
Less than high school 166 (34%) 437.94 (93.47–2779.17) 6.78 (0.00–35.12) 2.74 (0.00–30.01) 0.68 (0.33–1.34)
Some college 75 (15%) 415.24 (195.26–1600.50) 7.08 (0.00–56.00) 3.18 (0.00–119.67) 0.72 (0.48–1.54)
Body Mass Index (kg/m2)
18.5–24.99 195 (41%) 482.78 (93.47–2779.17) 8.35 (0.00–173.86) 3.95 (0.00–218.44) 0.70 (0.40–1.22)
25–29.99 149 (31%) 436.88 (140.80–3664.91) 6.92 (0.41–52.23) 2.75 (0.00–130.60) 0.69 (0.30–1.34)
>29.99 135 (28%) 392.29 (56.13–1570.18) 5.85 (0.00–39.70) 2.78 (0.00–36.57) 0.71 (0.40–1.54)
Smoking status
No smoking 358 (74%) 450.11 (93.47–2779.17) 7.91 (0.00–173.86) 3.31 (0.00–218.44) 0.70 (0.30–1.34)
Smoking prior to pregnancy 49 (10%) 433.03 (195.26–3664.91) 7.71 (0.00–70.22) 3.42 (0.00–129.48) 0.65 (0.44–1.04)
Smoking during pregnancy 79 (16%) 447.62 (56.13–1570.18) 5.27 (0.35–39.70) 2.74 (0.30–130.60) 0.71 (0.40–1.54)
Folic acid supplementation
Yes 433 (89%) 441.19 (56.13–2779.17) 7.04 (0.00–76.90) 3.08 (0.00–186.65) 0.70 (0.30–1.54)
No 52 (11%) 461.59 (143.07–3664.91) 9.87 (2.34–173.86) 3.49 (0.00–218.44) 0.69 (0.45–1.19)
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Table 1 Study participant characteristics by maternal B vitamin concentrations: Newborn Epigenetic STudy (N = 496) (Continued)
Gestational diabetes
No 461 (94%) 447.62 (56.13–3664.91) 7.35 (0.00–173.86) 3.10 (0.00–218.44) 0.69 (0.30–1.54)
Yes 30 (6%) 415.23 (195.26–841.23) 9.07 (1.43–33.29) 3.41 (0.93–36.57) 0.72 (0.53–1.07)
Gestational age at blood draw
1st trimester 316 (64%) 455.71 (56.13–3664.91) 8.85 (0.00–173.86) 3.51 (0.00–218.44) 0.71 (0.30–1.54)
2nd trimester 166 (33%) 415.23 (109.44–2779.17) 5.77 (0.00–32.19) 2.70 (0.00–36.57) 0.66 (0.40–1.34)
3rd trimester 15 (3%) 301.80 (216.96–759.84) 3.06 (0.35–11.64) 2.16 (0.00–30.01) 0.62 (0.44–1.03)
Infant sex
Male 248 (50%) 444.75 (109.44–3664.91) 7.33 (0.00–76.90) 3.25 (0.00–179.19) 0.70 (0.33–1.19)
Female 249 (50%) 447.77 (56.13–2779.17) 7.54 (0.00–173.86) 3.18 (0.00–218.44) 0.69 (0.30–1.54)
B12 vitamin B12, PLP pyridoxal phosphate, PA 4-pyridoxic acid, Hcy homocysteine
Table 2 Adjusted regression coefficients for maternal B vitamins and birth weight by infant sex: Newborn Epigenetic STudy (N = 496)
Infant sex
All participants (N = 496) Male infants (N = 248) Female infants (N = 248)
Maternal B vitamin β coefficient, standard error, p value
B12
≤322.47 ng/L Reference Reference Reference
322.48–446.04 ng/L −12.89,70.83, 0.86 59.38, 104.12,0.58 −29.38, 101.01,0.77
446.05–575.51 ng/L −35.89, 69.24, 0.60 −59.18, 105.57,0.58 13.55, 95.10, 0.88
>575.51 ng/L 1.85, 69.82, 0.98 108.19, 100.01,0.28 −63.02, 99.61,0.53
p for interaction 0.5276
PLP
≤3.76 nM/L Reference Reference Reference
3.77–7.47 nM/L −72.75, 71.50, 0.31 3.37, 106.39, 0.97 −126.43, 102.07, 0.22
7.48–12.05 nM/L −45.61, 73.22, 0.53 −28.02, 114.15, 0.81 −15.02, 99.25, 0.88
>12.05 nM/L 39.81, 75.75, 0.60 43.48, 119.08,0.72 56.05, 100.69, 0.58
p for interaction 0.7014
PA
≤2.06 nM/L Reference Reference Reference
2.07–3.21 nM/L −13.80,70.48, 0.84 −50.67, 108.60, 0.64 49.43, 96.66, 0.61
3.22–5.93 nM/L −35.02,70.51,0.62 −7.31, 107.61,0.95 −36.80, 95.43,0.70
>5.93 nM/L 9.95, 72.43, 0.89 16.03, 112.20, 0.89 35.43, 97.44, 0.72
p for interaction 0.9134
Hcy
≤4.40 umol/L Reference Reference Reference
4.41–5.10 umol/L −57.72, 70.94, 0.42 −143.95, 108.74, 0.19 27.65, 95.21, 0.77
5.11–6.00 umol/L −72.86,71.21,0.31 −275.57, 105.70,0.01 76.91, 98.03, 0.43
>6.00 umol/L −87.21, 70.48, 0.22 −210.40, 102.08, 0.04 27.33, 98.14, 0.78
p for interaction 0.1021
Adjusted for gestational age at delivery, gestational age at blood draw, maternal pre-pregnancy body mass index, maternal race/ethnicity, parity, household income and
maternal smoking
B12 vitamin B12, PLP pyridoxal phosphate, PA 4-pyridoxic acid, Hcy homocysteine
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DMRs, previously shown to associate with fetal growth
in our study population [17, 18]. Mean methylation %
(standard deviation) for differentially methylated regions
by quartile of maternal B-vitamin status are provided in
Additional file 2: Table S2. After adjusting for gestational
age at delivery, gestational age at blood draw, maternal
race/ethnicity, maternal smoking, and pre-pregnancy
BMI, we found that PLP was positively associated with
methylation at the MEG3 DMR, consistent with a
threshold effect (βQuartile 3 = 2.01 and βQuartile 4 = 3.24,
p ≤ 0.05) (Table 4). No association was found between
maternal micronutrient levels and DNA methylation at
other DMRs. It is possible that intraindividual variabil-
ity between replicate measures could be greater than
the interindividual variability across samples, which
would make it difficult to decipher true differences
due to exposure versus differences that occur natur-
ally in the population. For each of the DMRs
analyzed herein, the interindividual variability
exceeded the intraindividual variability (Fig. 1), sup-
porting the validity of the association identified.
Discussion
Our study did not find evidence of an association be-
tween maternal micronutrient concentrations and birth
weight overall, but we observed that higher maternal
Hcy concentration was associated with lower birth
weight in male infants. The offspring of the mothers in
the highest concentrations of B12 had lower WG com-
pared to the offspring of the mothers in the lowest quar-
tile, and higher WG was observed among male offspring
of the mothers in the highest quartile of maternal PLP.
Maternal PLP concentrations were positively associated
with methylation at the MEG3 DMR.
Vitamin B12 is essential for cellular growth and differen-
tiation, as well as for DNA methylation, and could be an
Table 3 Maternal B vitamins and 3-year weight gain by infant sex: Newborn Epigenetics STudy (N = 273)
Infant sex
All participants (N = 273) Male children (N-137) Female children (N = 136)
Maternal B vitamin β coefficient, standard error, p value
B12
≤322.47 ng/L Reference Reference Reference
322.48–446.04 ng/L −381.14, 732.87, 0.60 33.23, 1199.92, 0.98 −625.74, 891.01, 0.49
446.05–575.51 ng/L −1395.75, 673.18, 0.04 −1010.30, 1086.31, 0.36 −1782.25,711.58, 0.02
>575.51 ng/L −2203.03, 722.49, 0.003 −2154.17, 1224.31, 0.09 −1626.59, 837.17, 0.07
p for interaction 0.6998
PLP
≤3.76 nM/L Reference Reference Reference
3.77–7.47 nM/L 448.65, 839.88, 0.60 1116.26, 1213.31,0.37 −1964.83, 1063.30, 0.08
7.48–12.05 nM/L 694.16, 897.50, 0.44 1220.60, 1530.15, 0.43 −1778.70, 1006.86, 0.09
>12.05 nM/L 1181.95, 866.33, 0.18 2943.29, 1365.99, 0.04 −1737.49, 936.33, 0.08
p for interaction 0.1018
PA
≤2.06 nM/L Reference Reference Reference
2.07–3.21 nM/L −268.93, 891.83, 0.76 391.05, 1476.59, 0.79 −1041.07,938.43, 0.28
3.22–5.93 nM/L −997.02, 778.44, 0.20 784.35, 1434.70, 0.59 −2307.87, 718.25, 0.005
>5.93 nM/L −294.59, 826.98, 0.72 983.67, 1525.03, 0.52 −1334.04, 689.14, 0.07
p for interaction 0.2046
Hcy
≤4.40 umol/L Reference Reference Reference
4.41–5.10 umol/L 227.32, 755.24, 0.76 −692.64, 1335.38, 0.61 63.93,715.18, 0.93
5.11–6.00 umol/L 71.24,793.17, 0.93 −1992.29, 1505.14,0.20 730.08, 837.30, 0.40
>6.00 umol/L −217.90,795.33, 0.79 −1256.44, 1479.32, 0.40 554.96, 878.78, 0.54
p for interaction 0.7041
Adjusted for gestational age at blood draw, maternal pre-pregnancy body mass index, household income, maternal race/ethnicity, breastfeeding, and caloric intake at
age 3
BMI body mass index, B12 vitamin B12, PLP pyridoxal phosphate, PA 4-pyridoxic acid, Hcy homocysteine
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independent factor for fetal development [19]. Pregnancy-
associated declines in B12 are common but are likely
attributed to increased fetal absorption and placental
transport [20]. The literature on the association between
maternal vitamin B12 status and adverse pregnancy out-
comes are mixed. A single study conducted among a co-
hort of pregnant women in Bangalore, India, showed that
low maternal B12 concentrations were associated with ele-
vated risk of intrauterine growth restriction (IUGR) [21].
However, several other investigations report no significant
association between maternal B12 status (measured at vari-
ous time points during the prenatal period) and birth
weight or IUGR [7, 8, 22]. We similarly found no associ-
ation with birth weight. To our knowledge, we are the first
to report on the association between maternal concentra-
tions of vitamin B12 and offspring WG at age 3 years. Our
finding of an inverse association between maternal B12
concentrations and WG could suggest that maternal B
vitamins during the prenatal period have downstream
effects on offspring body size, and these associations may,
in part, drive the inverse relationship between childhood
B12 concentrations and obesity [23].
Table 4 Adjusted regression coefficients for maternal B vitamins and infant differentially methylated regions: Newborn Epigenetic
STudy (N = 429)
H19 DMR MEG3 DMR SGCE/PEG10 DMR PLAGL1 DMR
mean methylation % (standard deviation)
47.93 (3.82) 72.64 (5.55) 45.98 (5.17) 57.79 (6.33)
Maternal B vitamins β coefficient, Standard Error, p value
B12
≤322.47 ng/L Reference Reference Reference Reference
322.48–446.04 ng/L 0.53, 0.57, 0.35 0.53, 0.85, 0.53 0.01, 0.66, 0.98 0.39, 0.95, 0.68
446.05–575.51 ng/L 0.68, 0.56, 0.22 0.01, 0.82, 0.99 0.26, 0.66, 0.70 0.58, 0.94, 0.54
>575.51 ng/L −0.41, 0.57, 0.48 −0.93, 0.85, 0.27 0.47, 0.67, 0.48 1.79, 0.96, 0.06
PLP
≤3.76 nM/L Reference Reference Reference Reference
3.77–7.47 nM/L −0.15, 0.60, 0.80 0.23, 0.83, 0.79 0.99, 0.75, 0.19 −0.02, 0.98, 0.99
7.48–12.05 nM/L −0.68, 0.62, 0.28 2.01, 0.89, 0.03 −0.33, 0.79, 0.68 −0.26, 1.02, 0.80
>12.05 nM/L −0.07, 0.63, 0.91 3.24, 0.89, <0.01 −0.30, 0.81,0.71 −0.11, 1.04, 0.91
PA
≤2.06 nM/L Reference Reference Reference Reference
2.07–3.21 nM/L −0.45, 0.58, 0.44 −0.18,0.84, 0.83 1.46, 0.74, 0.05 1.27, 0.95,0.18
3.22–5.93 nM/L −0.09, 0.60, 0.88 −0.24, 0.87, 0.79 0.79, 0.75, 0.29 1.54, 0.98, 0.12
>5.93 nM/L −0.57, 0.61,0.35 1.62, 0.87, 0.06 0.08, 0.78, 0.92 −0.15, 0.99, 0.88
Hcy
≤4.40 umol/L Reference Reference Reference Reference
4.41–5.10 umol/L 1.01, 0.59, 0.09 1.49, 0.87, 0.09 1.43, 0.77, 0.06 1.46, 0.98, 0.14
5.11–6.00 umol/L −0.97, 0.58, 0.10 1.07, 0.86, 0.21 1.19, 0.76, 0.12 1.77, 0.97, 0.07
>6.00 umol/L 0.19, 0.60, 0.75 1.60, 0.87, 0.07 1.36, 0.79, 0.09 1.10, 0.98, 0.27
Adjusted for gestational age at delivery, gestational age at blood draw, maternal race/ethnicity, maternal smoking and pre-pregnancy body mass index
DMR differentially methylated region, B12 vitamin B12, PLP pyridoxal phosphate, PA 4-pyridoxic acid, Hcy homocysteine
Fig. 1 Interindividual variability exceeds intraindividual variability in
DNA methylation at imprinted DMRs. Shown are the mean
methylation levels, ± standard deviation for the four DMRs analyzed,
alongside the means for technical replicates that were run alongside
for a subset of the samples (~2 % of the total)
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Plasma PLP, the best single indicator of vitamin B6
status, is involved in many aspects of macronutrient
metabolism and is known to decline during gestation
[24]. Several studies report positive associations between
maternal B6 supplementation and birth weight, including
a recent meta-analysis where a 217-g difference (95 % CI:
130–304; p = 0.009) was observed [24]. We observed a
monotonic increase in birth weight with increasing
maternal PLP concentration, but the effect was small
and insignificant. We found no previous studies that
examined the association between maternal PLP and
offspring WG, and anthropometric data on children
whose mothers received vitamin B6 supplements dur-
ing pregnancy are not available.
The concentrations of Hcy, a sulfur-containing amino
acid, are tightly regulated by two enzymatic pathways:
(1) Hcy can be remethylated to methionine by a pathway
requiring folate and vitamin B12 as a methyl donor and
co-factor, respectively, or (2) Hcy may be removed by
transsulfuration, a pathway reliant on vitamin B6 [25].
Therefore, deficiencies of folate, vitamin B12, or vitamin
B6 are likely to lead to increase Hcy. Blood concentra-
tions of Hcy during pregnancy are variable: a slight de-
crease during early gestation; a nadir between 20 and
32 weeks; and subsequent rise after delivery [26]. Investi-
gations of the association between maternal total Hcy
and birth weight have yielded diverging results. Many,
but not all [7], studies have observed an increased risk
of LBW or IUGR in women with elevated levels of total
Hcy [27, 28] and a recent meta-analysis showed that hy-
perhomocysteinaemia (>90th percentile) was associated
with a 25 % increased odds of being SGA (95 % CI: 1.09,
1.44) [29]. While we found no statistically significant as-
sociations between Hcy and birth weight overall, we did
observe a novel inverse association among male infants.
No previous study had evaluated WG or BMI with pre-
natal maternal Hcy concentrations, and our study found
no significant associations.
The association between nutrients in the one-carbon
pathway and offspring methylation are well-documented
in animal models [30, 31], but studies among humans
are limited. A cross-sectional study assessing maternal
vitamin B12 status at the time of parturition found in-
verse associations with umbilical cord blood IGF2 DMR
methylation [13]. Another study showed associations be-
tween plasma levels of Hcy and cord blood DNA methy-
lation of 289 CpG sites [32]. A recent investigation of
dietary nutrients showed maternal vitamin B2 intake was
positively correlated with PLAGL1 DMR methylation in
umbilical cord blood, although no association was found
with B6 or B12 [15]. These investigations were limited by
cross-sectional data collection, small samples, and inad-
equate assessment of maternal micronutrient status.
While these associations may be by chance, our study is
the first to show an association between maternal PLP
and offspring methylation at the MEG3 DMR which could
be an important epigenetic tag for maternal B vitamin
adequacy. Vitamin B6 is integrally involved in the 1-CC
metabolism pathway and acts as a co-factor for epigenetic
processes including DNA methylation [10]. Insufficient
maternal micronutrients may affect the efficiency of the
one-carbon pathway, interfering with DNA methylation
and epigenetic regulation of genes such as MEG3 during
critical periods of development. MEG3 produces a long
non-coding RNA and altered expression is associated with
multiple disorders including the chromosome 14 unipa-
rental disomies [33].
Strengths of our study include its large population-
based sample, prospective design, and use of blood bio-
markers to assess maternal micronutrient status. We
were additionally able to consider adjustment for and
present results stratified by FA supplementatio-
n—although cells became small. Although we observed
associations between maternal micronutrients, birth
weight, childhood WG, and the MEG3 DMR, these find-
ings should be interpreted in context of the study limita-
tions. While our findings could be due to chance, by
considering a small number of DMRs (N = 4) for which
we had strong biologic rationale, we (1) mitigate con-
cerns regarding multiple comparisons; (2) reduce the
likelihood of type II error; and (3) generate data which
may be replicated in future studies. We assessed mater-
nal micronutrient concentrations at a single time point
and for a large proportion of women data were unavail-
able. Further, LBW and macrosomia were infrequent in
our study population and were unable to examine asso-
ciations with birth weight extremes. While we are the
first to estimate associations between maternal B vitamin
and Hcy concentrations and childhood WG, in some,
strata sample size was reduced considerably. Finally,
while there is an urgent need to better understand how
maternal micronutrients involved in the 1-CC metabolism
pathway affect developmental epigenetics, redundancy in
methyl-donor supply pathways may indicate that alter-
ations of one substrate could, through compensatory
mechanisms, perturb others [34]. A more comprehensive
approach is necessary to gain a complete understanding of
how these nutrients affect DNA methylation in a larger
number of regulatory regions.
Conclusions
Our study, in a large ethnically diverse cohort of mothers
and their offspring, suggests that with the exception of a
sex-specific effect for Hcy, B vitamins are not associated
with birth weight. However, both B12 and PLP appear to
be associated with 3-year WG. We further showed that
maternal PLP concentrations were positively associated
with methylation at the MEG3 DMR and may be
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important for understanding the effects of prenatal nutri-
tion on adult health outcomes. The association between
specific maternal micronutrients on the 1-CC metabolism
pathway and adverse pregnancy outcomes continue to be
an area of clinical and public health significance. Add-
itional studies in large prospective birth cohorts may aid
in understanding their independent and cooperative ef-
fects on fetal health, childhood outcomes, and adult dis-
ease risk. Additional mechanistic insights on the role of
these nutrients and DNA methylation could provide epi-
genetic targets for surveillance and intervention.
Methods
Ethics, consent, and permissions
The study protocol was approved by the Duke University,
Durham Regional Hospital and North Carolina State
University Institutional Review Boards. Written, informed
consent was obtained for all study participants prior to
data collection.
Study participants
The study participants were enrolled as part of the New-
born Epigenetics STudy (NEST), a prospective study of
women and their offspring. Methods for enrollment of the
study participants have been previously described [35].
Briefly, between 2009 and 2011, English- or Spanish-
speaking pregnant women ≥18 years were identified from
clinic logs of five prenatal clinics and obstetric facilities in
Durham County, NC, USA. Women were excluded from
the study if they did not intend to use one of the participat-
ing obstetric facilities for delivery, planned to relinquish
custody of the child, move from the area in the subsequent
3 years, or had established HIV infection. Among 2548 eli-
gible women, 1700 (66.7 %) were consented and enrolled.
Women enrolled in the study were similar to those who de-
clined with respect to age (p = 0.66) but dissimilar with re-
spect to race (p < 0.001), where non-participating women
were more likely to be Asian and Native American. Among
the 1700 consenting women, 115 were excluded due to in-
fant deaths before, during, or soon after birth. An additional
281 who were illiterate, underage, refused further participa-
tion or could not be located were excluded, such that 1304
(76.7 %) remained in the study. Of the remaining women,
we measured B vitamin/Hcy concentrations from the ma-
ternal venous blood of the first 528, 63 % of which was
drawn during the first trimester. These analyses are re-
stricted to the 496 singleton infant-mother pairs in whose
blood draw and birth weight data were available.
Data collection
Data collection occurred at multiple time points through-
out the study period as follows: (1) upon enrollment, partic-
ipants provided peripheral blood samples (gestational age
at enrollment: range = 4.0–32.5 weeks, mean = 12 weeks)
and completed a self-administered questionnaire which
queried women on their sociodemographic, reproductive,
and lifestyle characteristics in the 6 months prior; (2) upon
delivery, birth outcomes were abstracted from medical
records and infant cord blood specimens were obtained to
assess offspring methylation; and (3) at age 3 years, data on
child anthropometry and dietary characteristics were ob-
tained for 273 of the 496 offspring for whom maternal B
vitamins were measured. The participants with and without
childhood data did not differ with respect to key variables
(e.g., maternal age, micronutrient concentrations, and birth
weight [p > 0.05]).
Measurement of maternal micronutrient concentrations
(e.g., B12, PLP, PA and Hcy)
Quantitative analysis of plasma B12 was performed using
the commercial kit, ID-Vit Vitamin B12 (Immundiagnos-
tic-ALPCO; Salem, NH, Ref KIF012) according to the
manufacturer’s instructions. The kit uses the vitamin
B12-dependent strain Lactobacillus delbruekii subsp.
lactis (ATCC 7830) in a 96-well format. After processing,
L. delbruekii growth was measured by turbidimetry at
610 nm using the Molecular Devices, Versa-Max Tun-
able Plate Reader. Data analysis was performed using the
commercially available software Soft-Max version 3.1,
Molecular Devices. PLP and PA were measured by high-
performance liquid chromatography (HPLC) which re-
quires the removal of plasma protein, conversion of the
liberated PLP to 4-pyridoxic acid 5′-phosphate in alkaline
medium containing cyanide (derivatization), followed by
acidification. The acidified samples were subjected to re-
versed phase HPLC separation, and detection was carried
out with fluorescence with excitation at 320 nm; emission
at 416. A Thermo Separation Products System, pump
model P200, autosampler model AS300, fluorescence de-
tector model FL300 was used. Plasma Hcy was similarly
assessed using HPLC with UV detection at 384 nm.
Maternal micronutrient concentrations were right skewed
and quartiled.
Assessment of birth and childhood outcomes
Trained personnel abstracted parturition data from med-
ical records after delivery. These data included birth
weight, gestational age at birth (week), and infant sex. In-
fant birth weight (grams [g]) showed no evidence of de-
parture from normality and was analyzed as a continuous
variable. Age 3 WG (g) was slightly right skewed and cal-
culated using the following formula: ((age 3 weight [g]/age
at which weight was obtained [months])*36 months) −
birth weight [g] and assessed continuously.
Assessment of covariates and effect measure modifiers
The participants self-reported maternal age at delivery,
race/ethnicity, marital status, parity, diabetes, and weight
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and height at last menstrual period (LMP), all of which
were subsequently verified with abstracted medical re-
cords. Household income, maternal education, cigarette
smoking, FA supplementation, and infant feeding prac-
tices were self-reported via questionnaire.
We considered maternal race/ethnicity, infant sex, ma-
ternal pre-pregnancy BMI, and FA supplementation as
potential modifiers of the association between maternal
micronutrient concentrations and birth weight. Race/
ethnic categories were assigned based on women’s self-
identification as Black/African American, non-Hispanic
White, or Hispanic White. Infant sex was abstracted
from medical records. Maternal BMI was calculated
from self-reported weight (kg) and height (m) at LMP
and expressed as kg/m2. FA supplementation was self-
reported at baseline.
DNA methylation analysis
Infant genomic DNA (800 ng) was modified by treatment
with sodium bisulfite using the Zymo EZ DNA Methyla-
tion kit (Zymo Research; Irvine, CA, USA). Bisulfite treat-
ment of denatured DNA converts all unmethylated
cytosines to uracils but leaves methylated cytosines un-
changed, allowing quantitative definition of cytosine
methylation status. Pyrosequencing was performed using
Pyromark Q96 MD pyrosequencers (Qiagen) to measure
DNA methylation at four imprint regulatory regions
known to associate with fetal growth and development in
NEST study participants [17, 18] including the following:
the H19 DMR regulating the IGF2/H19 domain, the
MEG3 DMR regulating the DLK1/MEG3 domain, the
SGCE/PEG10 DMR positioned between epsilon sarcogly-
can and paternally expressed gene 10, and the PLAGL1
DMR [36]. Assays were designed to query established
DMRs using the Pyromark Assay Design Software
(Qiagen). Polymerase chain reaction (PCR) conditions
were optimized to produce a single, robust amplifica-
tion product by adjusting annealing temperature and
magnesium chloride concentrations. The primers,
chromosomal location, and coordinates along with the
PCR conditions for all four regions investigated here
were previously provided [36]. Defined mixtures of
fully methylated and unmethylated control DNAs were
used to show a linear increase in detection of methyla-
tion values as the level of input DNA methylation in-
creased (Pearson r > 0.99 for all DMRs). Once the
optimal conditions were defined, each DMR was ana-
lyzed using the same amount of input DNA from each
specimen (40 ng, assuming complete recovery follow-
ing bisulfite modification), keeping the thermocycler
and pyrosequencer constant. Controls to determine
the bisulfite conversion efficiency were included for
each DMR with every sample run. For all data included
in the analysis, the conversion efficiency exceeded
97 %. Percent methylation for each CpG cytosine was
determined using Pyro Q-CpG Software (Qiagen). We
interrogated between four and eight CpG sites per DMR:
four for H19, eight for MEG3, six for SGCE/PEG10, and
six for PLAGL1.
Statistical analysis
We compared the distribution of demographic and ob-
stetric characteristics across quartiles of B12, PLP, PA,
and Hcy using chi-squared tests [37]. Generalized linear
models were used to estimate the association between
maternal micronutrient concentrations (at enrollment)
and birth weight as well as age 3 WG [38] (a priori two-
sided p ≤ 0.05). For all models, we considered adjustment
for the following covariates: maternal age, race/ethnicity,
gestational age at delivery, marital status, parity upon
enrollment, household, maternal education, maternal
BMI at LMP, maternal smoking, maternal FA supple-
mentation, gestational diabetes, gestational age at blood
draw, and infant sex. For childhood WG analyses, we
additionally considered adjustment for every breastfeed-
ing, in-home smoking, height, and caloric intake at age
3 years. Final confounders were selected based on directed
acyclic graphs [39] and backward elimination [40].
Among 429 term mother-infant pairs where methylation
data for at least one of four DMRs was available and nutri-
ent data were measured, we examined associations with
maternal micronutrient concentrations. Study participants
with DMR data available were similar to those without
DMR data with respect to maternal age, micronutrient con-
centrations, and birth weight (p values >0.05). Cronbach’s
alphas were >0.89 for all DMRs considered, suggesting
mean methylation levels for each DMR could be used in
our models [35]. We used F tests [40] for parametric ana-
lyses and Wilcoxon rank-sum tests [37] to examine DNA
methylation levels by maternal micronutrient concentra-
tion, adjusting for factors shown to influence DNA methy-
lation [41] (a priori p ≤ 0.05). All statistical analyses were
conducted in SAS v9.3 (SAS Institute, Cary, NC, USA).
Availability of Supporting Data
The data set supporting the results of this epidemiologic
research will be available with appropriate human sub-
ject protection in a separate file.
Additional files
Additional file 1: Table S1. Maternal B vitamins and infant birth weight
associations by folic acid supplementation: Newborn Epigenetic Study
(N = 484). Adjusted regression coefficients and standard errors for the
association between maternal B vitamins (cobalamin [B12], pyridoxal
phosphate [PLP], 4-pyridoxic acid [PA] and homocysteine [Hcy]) and infant
birth weight in strata of folic acid supplementation: Newborn Epigenetic
STudy.
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Additional file 2: Table S2. Mean methylation percentage (standard
deviation) for differentially methylated regions by quartile of maternal B
vitamin status. Newborn Epigenetic STudy (N = 429). Mean methylation
percentage (standard deviation) for differentially methylated regions by
quartile of maternal B vitamins (cobalamin [B12], pyridoxal phosphate
[PLP], 4-pyridoxic acid [PA], and homocysteine [Hcy]).
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